Nobel Laureate Offers Insight into Brain Function
The scientist whose research led to the discovery of the most common drug used to treat Parkinson's disease will speak Oct. 20 at UC.
Arvid Carlsson, MD, PhD, was awarded the Nobel Prize in Physiology or Medicine in 2000 for his discovery of the role of dopamine, a naturally occurring chemical "messenger" in the brain, in controlling movement. Dr. Carlsson, emeritus professor of pharmacology at the University of Gothenburg, Sweden, will present "The Dopamine System: Still an Important Target for Drug Discovery" at the annual Louis Lurie Memorial Lecture at 10:30 a.m., Wednesday, Oct. 20.
Louis Lurie, MD, was a pioneer in Cincinnati psychiatry. In 1920 he founded the Psychopathic Institute-which later became the Children's Psychiatric Center-and served as its director until 1948. A founding member of the American Academy of Child Psychiatry and president of the Cincinnati Society of Neurology and Psychiatry, Dr. Lurie died in 1979 at age 91.
For more information, call 513-558-4621.
Tags
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
Bidirectional link between oral, kidney health calls for patient education, access
August 4, 2026
Despite growing awareness of the connection between oral health and chronic health conditions, patient awareness and access to dental care remain limited, according to University of Cincinnati experts who recently spoke with Healio | Nephrology News & Issues.